ATRT-02. Neuropsychological function in infant atypical teratoid/rhabdoid tumor versus low-grade glioma survivors reflects tumor malignancy and multimodal treatment
Thomas Traunwieser(University Hospital Augsburg), Michael C. Frühwald(University Hospital Augsburg), Elena Loos(University Hospital Augsburg), Daniela Kandels(University of Augsburg), Anne Neumann‐Holbeck(Universität Hamburg), Petra Neumayer(University Hospital Augsburg), Andrea Kreisch(University Hospital Carl Gustav Carus), Astrid Gnekow(University Hospital Augsburg), Joy Siebrands(Goethe University Frankfurt), Walther Stamm(University Children's Hospital Tübingen), Jenny Prüfe(Heidelberg University), Beate Timmermann(Essen University Hospital), Kristin Faulstich‐Ritter(Universität Ulm), Eva Manteufel(Justus-Liebig-Universität Gießen), Katja Baust(University Hospital Bonn), Karolina Nemes, Alexandra Nest(University Children's Hospital Tübingen), Peggy Lüttich(German Cancer Research Center), Joachim Gerß, Lisa Schubert(Universitätsklinikum Würzburg), Rainer John(Humboldt-Universität zu Berlin)
Cited by 0
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419